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BACKGROUND: Ventilator injury has been implicated in the pathogenesis of bronchopulmonary dysplasia. Avoiding
invasive ventilation could reduce lung injury, and early respiratory management may affect pulmonary outcomes.
OBJECTIVE: To analyze the effect of initial respiratory support on survival without bronchopulmonary dysplasia at a
gestational age of 36 weeks.
DESIGN/METHODS: A prospective 3-year observational study. Preterm infants of ,32 weeks gestational age were
classified into 4 groups according to the support needed during the first 2 hours of life: room air, nasal continuous
positive airway pressure, intubation/surfactant/extubation and prolonged mechanical ventilation (defined as
needing mechanical ventilation for more than 2 hours).
RESULTS: Of the 329 eligible patients, a total of 49% did not need intubation, and 68.4% did not require prolonged
mechanical ventilation. At a gestational age of 26 weeks, there was a significant correlation between survival
without bronchopulmonary dysplasia and initial respiratory support. Preterm infants requiring mechanical
ventilation showed a higher risk of death and bronchopulmonary dysplasia. After controlling for gestational
age, antenatal corticosteroid use, maternal preeclampsia and chorioamnionitis, the survival rate without
bronchopulmonary dysplasia remained significantly lower in the mechanically ventilated group.
CONCLUSIONS: In our population, the need for more than 2 hours of mechanical ventilation predicted the
development of bronchopulmonary dysplasia in preterm infants with a gestational age .26 weeks (sensitiv-
ity=89.5% and specificity=67%). The need for prolonged mechanical ventilation could be an early marker for the
development of bronchopulmonary dysplasia. This finding could help identify a target population with a high risk
of chronic lung disease. Future research is needed to determine other strategies to prevent bronchopulmonary
dysplasia in this high-risk group of patients.
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INTRODUCTION
Bronchopulmonary dysplasia (BPD) affects thousands of
preterm infants each year. The use of antenatal corticoster-
oids, postnatal surfactant therapy and modern intensive
care has modified BPD into a less-severe disease that is
characterized by arrested lung development.
1 The key
factors in BPD’s pathogenesis are extreme lung immaturity,
antenatal and postnatal inflammation, and the effects of
oxygen and mechanical ventilation.
2-4
Because ventilator-induced lung injury is a major con-
tributing factor to BPD,
5 early respiratory management in
preterm infants may affect pulmonary outcomes. The use of
positive end-expiratory pressure (PEEP) at delivery
6-8 and
early postnatal nasal continuous positive airway pressure
(nCPAP) may be beneficial in reducing the need for
intubation and mechanical ventilation and in preventing
chronic lung disease (CLD).
9-12 It has been suggested that
avoiding ventilator-induced injury may be an effective way
to reduce the incidence of BPD.
13 Retrospective data suggest
that preterm infants supported by nCPAP from delivery
have shorter hospital stays and less surfactant use and that
these infants are less likely to develop CLD (although not
significantly so). However, randomized clinical trials have
demonstrated no effect of prophylactic CPAP in reducing
the incidence of BPD.
14,15
Since September 2003, our regular practice for the
respiratory support of preterm infants below 32 weeks of
gestational age (GA) has been modified to prevent tracheal
intubation by giving prophylactic CPAP in the delivery
room to all spontaneously breathing infants. Those infants
requiring surfactant treatment are extubated to nCPAP as
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823soon as possible (ideally, with less than two hours of
mechanical ventilation). We performed a prospective,
observational study of all inborn admissions with a GA of
less than 32 weeks from January 2004 to December 2006. We
analyzed the risk of BPD and/or mortality according to the
initial respiratory support needed.
DESIGN
A prospective, observational study conducted in the
Neonatology Service of the Hospital General Universitario
Gregorio Maran ˜o ´n from January 2004 to December 2006.
Patients
All preterm infants of ,32 weeks GA and free from major
congenital abnormalities were eligible for this study.
Methods
All preterm infants of ,32 weeks GA who had sponta-
neous respiratory effort in the delivery room were given
noninvasive continuous airway pressure support through a
Neopuff infant resuscitator (Fisher & Paykel Healthcare
Corporation Limited, Auckland, New Zealand). The
Neopuff delivers oxygen from a blender at concentrations
ranging from 21% to 100%. The patients’ T-pieces were
connected to neonatal masks. The peak inspiratory pressure
(PIP) (,20 cm H2O) and PEEP (5 cm H2O) were preset by
the neonatologist before delivery and checked using the
integrated manometer. A valve on the T-piece provided
PEEP. The PIP and PEEP levels were constant and were
maintained automatically for every breath.
The infants were categorized into 1 of 4 groups, based on
the respiratory support needed during the first 2 hours of
life to maintain the following targets in capillary blood
samples: an oxygen saturation of 88% to 92%, a pH .7.25,
and a PCO2 ,60 mm Hg. No active intervention or
randomization was undertaken by the attending physicians;
the infants were classified solely on the basis of their
respiratory situation. Outcomes in the first 72 hours of life
were used to determine the success or failure of the
respiratory support.
The following respiratory support categories were used:
the infants in Group 1 received prophylactic CPAP but not
supplemental oxygen in the delivery room and did not
develop respiratory distress syndrome; the infants in Group
2 received nasal CPAP (nCPAP) with a FiO2,30% due to
low oxygen saturation and an increased respiratory effort
after the prophylactic CPAP in the delivery room; the
infants in Group 3 received endotracheal intubation to
administer 100 mg/kg of exogenous surfactant (Survanta,
Abbott Laboratories,) and were extubated successfully to
nCPAP within the first two hours of mechanical ventilation
(intubation, surfactant, and extubation, or INSURE); and the
infants in Group 4 could not be extubated within the first
2 hours of mechanical ventilation and could not be
administered surfactant therapy due to high FiO2 require-
ments (.30%). The two-hour period was arbitrarily chosen
by the investigators. INSURE failure has been defined in the
literature as inability to extubate after 1 hour of surfactant
administration.
16,17
A low threshold for administering surfactant was used.
Surfactant was given to any infant receiving nCPAP at a
pressure .5c mH 20 who needed an FiO2 .30% to achieve a
target oxygen saturation between 88% and 92%. If the FiO2
requirements remained .30%, a second dose of surfactant
was given six hours after the first. Extubation was
attempted when there was an adequate spontaneous
respiratory effort, hemodynamic stability and an oxygen
saturation from 88% to 92% with an FiO2 ,30%. A loading
dose of intravenous theophylline, followed by oral caffeine,
was administered to all the infants on admission to the
NICU.
The data collected included patient demographics,
antenatal corticosteroid use (two 12 mg intramuscular
injections of betamethasone given 24 hours apart), pre-
eclampsia (development of new-onset hypertension with
proteinuria after 20 weeks gestation), chorioamnionitis
(defined as the presence of fever with one or more of the
following: maternal leukocytosis .15.000/mm
3, uterine
tenderness, fetal tachycardia, and foul-smelling amniotic
fluid)
18, surfactant therapy, survival without BPD at 36
weeks gestational age (as determined by the last menstrual
period),
19,20 the presence of an air leak (pneumothorax,
pneumomediastinum, or pulmonary interstitial emphy-
sema), a Papile’ Grade 3 or above intraventricular hemor-
rhage (IVH), necrotizing enterocolitis (NEC) requiring
surgery, a patent ductus arteriosus (PDA) requiring surgical
closure, Stage 3 or greater retinopathy of prematurity
(ROP) (using the International Classification of ROP) and
mortality.
Ethical committee approval was obtained for the publica-
tion of the results.
Outcome Measures
The primary outcome was survival without BPD at 36
weeks and its relation with the initial ventilatory support.
We also analyzed whether the need for prolonged
(.2 hours) mechanical ventilation after surfactant adminis-
tration could predict the development of BPD in preterm
infants.
The results were analyzed by the following gestational
age groups: ,26 weeks, 26-28 weeks, and .28 weeks.
Statistical Analysis
SPSS 15.0 was used for the data analysis. The categorical
data were analyzed using a chi-square or Fisher’s exact test
(where appropriate), and continuous variables were ana-
lyzed using an ANOVA model or a median test. A
multivariate regression model was used to adjust for the
differences between the groups in GA, gender, antenatal
corticosteroid administration, maternal preeclampsia and
chorioamnionitis.
RESULTS
A total of 343 preterm infants of less than 32 weeks GA
were delivered during the study period. Of these, 14 were
excluded because of major congenital abnormalities, leaving
329 eligible participants. The mean GA was 28.6 weeks
(range, 23.0-31.6 weeks), and the mean birth weight was
1.201 g (range, 430-2.100 g). The demographics of the study
population by the respiratory-support groups are shown in
Table 1.
In the nCPAP group, 18.7% of infants needed intubation
and exogenous surfactant due to an FiO2 requirement
.30%. In the INSURE group, 18.3% required reintubation
within the first 72 hours of life. Almost half of the preterm
infants (49%) did not require intubation (Groups 1 and 2),
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824and 68.4% did not require mechanical ventilation for more
than two hours (Groups 1, 2 and 3). The mean age for the
first dose of surfactant was 2 hours (Standard Deviation
(SD), 1.2 hours). A second dose of surfactant was adminis-
tered to 35% of the mechanically ventilated infants.
The distribution by GA of the infants into the different
respiratory-support groups is shown in Figure 1. The
success rates of nCPAP and INSURE (50% for both) were
significantly higher for those preterm infants of .26 weeks
GA.
The overall BPD-free survival (SF-BPD) rate at 36 weeks
GA was 72%: 12.5% for infants less than 25 weeks GA, 56.5%
for those of 26 to 28 weeks GA, and 93.4% for those of more
than 28 weeks GA (Figure 2).
There was a statistically significant difference in BPD-free
survival between the respiratory-support groups. The
infants in Group 1 had an SF-BPD rate of 100%. The SF-
BPD rate was 88.3% in the nCPAP group, it was 76.6% in the
INSURE group, and it was 36.5% in the mechanical-
ventilation group (p,0.01) (Figure 3). The nCPAP group
and the INSURE group did not have a statistically
significant difference in SF-BPD.
Table 2 shows the logistic-regression analyses of the
individual effects of GA, antenatal corticosteroid treatment,
maternal preeclampsia and chorioamnionitis on the SF-BPD
rate in both the nCPAP and INSURE groups. In a
multivariate model combining gestational age, antenatal
corticosteroid treatment, maternal preeclampsia and chor-
ioamnionitis, the SF-BPD rates in both the nCPAP and
INSURE groups were significantly higher than in the
prolonged-mechanical-ventilation group. The odds ratio
(OR) was 3.7 (p=0.03, 95% confidence interval (CI)=1.5-
8.8) for Group 2 and was 2.3 (p=0.05, 95% CI=1.0-5.5) for
Group 3. Regardless of the type of respiratory support, GA
was a protective factor, with an OR of 1.89 (p,0.01, 95%
CI=1.56-2.29). Preeclampsia was associated with an
increased likelihood of developing BPD, with an OR of
2.54 (p=0.03, 95% CI=1.08-5.97). Neither the antenatal
administration of corticosteroids nor maternal chorioamnio-
nitis modified the unadjusted OR, however.
An ROC curve was used to establish a GA threshold at
which the need for mechanical ventilation would be the best
predictor for later BPD. The need for prolonged mechanical
ventilation after a GA of 26 weeks predicted the develop-
ment of BPD with a sensitivity of 89.5% and a specificity of
67% (Figure 4).
Table 3 shows the adverse outcomes. Significantly higher
rates of air leaks (interstitial emphysema or pneumothorax),
PDA, IVH, ROP and mortality were associated with the
need for prolonged mechanical ventilation. There were no
significant differences in the rates of air leaks between the
nCPAP and INSURE groups. A logistic-regression analysis
that excluded Group 1 and controlled for GA revealed no
statistically significant difference in mortality between the
INSURE and nCPAP groups (p=0.28). When compared to
the nCPAP group, the odds ratio for mortality in Group 4
was 4.6 (p=0.02, 95% CI=1.23-17.2).
DISCUSSION
The best respiratory-therapy approach for preterm infants
in the delivery room remains a controversial issue. Due to
mechanical ventilation increasing the risk of BPD, most
neonatologists have focused on avoiding the use of
mechanical ventilation as much as possible.
13,21 The use of
nCPAP to prevent respiratory distress syndrome and the
need for intubation and exogenous surfactant administra-
tion are generally accepted.
22 Because nCPAP can be used
successfully in many preterm infants to avoid the need for
invasive mechanical ventilation and prevent lung injury, we
modified our clinical approach to respiratory support
Table 1 - The characteristics of the study population by the initial airway-management modality. The results are
expressed as the mean (SD).
All Group 1 Group 2 Group 3 Group 4 p
N=329 N=67 N=94 N=64 N=104
(20.4%) (28.6%) (19.5%) (31.6%)
Birth weight, g 1201 (376.8) 1565 (324.7) 1340 (272.2) 1298 (342.9) 1060 (353.8) 0.21
GA, weeks 28.6 (2.1) 30.2 (1.0) 29.4 (1.6) 28.5 (1.9) 26.9 (2.1) 0.00*
Gender, % male 54.4 50.7 51.1 60.9 55.7 0.58
Cord pH 7.29 (0.1) 7.34 (0.07) 7.28 (0.11) 7.31 (0.07) 7.26 (0.14) 0.21
Antenatal corticosteroids, % 62.3 71.6 68.1 62.5 51.0 0.02*
Chorioamnionitis, % 16.7 9.4 9.8 12.1 35.5 0.00*
Figure 1 - Respiratory support by GA (weeks). Figure 2 - Survival free of BPD (%) by GA.
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825during the first few hours of life for preterm infants younger
than,32 weeks GA. Prophylactic CPAP starting at delivery
was used in an attempt to open the infant’s lungs by
spontaneous respiratory effort. In our study, 49% of the
preterm infants of ,32 weeks gestational age did not need
intubation or mechanical ventilation, and 68.4% did not
require prolonged mechanical ventilation (.2 hours). These
data corroborate those of previous studies that have
suggested that it is possible to initiate nCPAP for even the
most immature neonates.
15,23,24 However, there is still a
need for invasive mechanical ventilation in some infants,
particularly in the younger GA groups.
25 In our study, we
showed that more than 95% of the infants younger than 25
weeks GA required invasive mechanical ventilation, and the
success rates for nCPAP and INSURE increased when the
GA was greater than 26 weeks.
We found a statistically significant difference in survival
without BPD at 36 weeks related to the initial respiratory
support needed. The preterm infants requiring mechanical
ventilation for more than two hours had a higher risk of
death and BPD than those successfully treated with room
air, nCPAP or INSURE. To minimize heterogeneity and
avoid confounding factors, a multivariate-regression model
was used to adjust for the differences between the groups.
With the obvious limitations of a descriptive study, we
found that the SF-BPD rate remained significantly lower in
the mechanically ventilated group than in the other groups
after controlling for differences in GA, antenatal corticoster-
oids, maternal preeclampsia and chorioamnionitis. Because
our study was non-interventional and because the preterm
infants were allocated to the groups based on the severity of
their respiratory failure, the nCPAP group was composed of
infants who were not severely ill. This factor may have been
one of the reasons for the significantly lower risk of
developing BPD. A randomized, controlled intervention
trial showed no benefit of nCPAP over invasive mechanical
ventilation in decreasing the rate of BPD.
24 Because the
patients with severe respiratory distress were in the
prolonged-mechanical-ventilation group, we found a higher
incidence of pneumothorax among these patients than in the
nCPAP group. Moreover, the INSURE-group infants were
less likely to develop pneumothorax (1.6%) than the nCPAP
group (4.3%). Both the nCPAP and INSURE groups had
lower short-term morbidity. The CPAP pressure applied,
the FiO2 chosen for the intubation and the use surfactant are
still matters of controversy.
26 In our study, an nCPAP of
5c mo fH 2O and an nFiO2 .30% were used as the criteria
for intubation and surfactant therapy, and this choice may
have modified the findings. The best approach is yet to be
Figure 4 - ROC curve. The need for prolonged mechanical
ventilation after a GA of 26 weeks was a good predictor for later
development of BDP (Sensitivity 89.5%, Specificity 67%).
Table 2 - The results of logistic-regression analyses assessing the individual effects of GA, antenatal corticosteroid
treatment, maternal pre-eclampsia and chorioamnionitis on the SF-BPD rate in the nCPAP and INSURE groups. The SF-
BPD rate in both these groups was significantly higher than in the prolonged-mechanical-ventilation group.
OR 95% CI p
Unadjusted CPAP 13.1 6.2 – 27.6 ,0.01
INSURE 5.7 2.8 – 11.4 ,0.01
Adjusted for antenatal corticosteroids CPAP 12.6 5.9 – 26.5 ,0.01
INSURE 5.5 2.7 – 11.2 ,0.01
Adjusted for chorioamnionitis CPAP 9.0 4.2 – 19.5 ,0.01
INSURE 3.9 1.8 – 8.2 ,0.01
Adjusted for GA CPAP 4.5 1.9 – 10.6 ,0.01
INSURE 3.3 1.5 – 7.4 0.04
Adjusted for GA, antenatal corticosteroids and chorioamnionitis CPAP 3.7 1.5 – 8.8 0.03
INSURE 2.3 1.0 – 5.5 0.05
Figure 3 - Survival free of BPD (%) by respiratory care groups.
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826determined and may be different in different gestational age
groups.
Our objective was not to compare respiratory strategies
but to analyze the severity of respiratory failure within the
first hours of life, with the aim of avoiding unnecessary
intubation. It seems that the need for mechanical ventilation
after the administration of exogenous surfactant may define
the risk for BPD.
Our study was not designed to analyze the relationship
between preeclampsia and BPD, but our data are consistent
with other existing reports showing a positive association
between those two pathologies.
27,28 Maternal preeclampsia
may impair fetal pulmonary development, thereby increas-
ing the risk of neonatal respiratory distress.
In conclusion, the need for prolonged mechanical ventila-
tion (more than 2 hours) may be an early marker for the
developmentofBPDinpreterminfantsofmorethan26weeks
GA. This association may help to identify a target population
with a high risk of BPD. Future research is needed to find
strategies to prevent BPD in this high-risk group of patients.
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CLINICS 2011;66(5):823-827 Initial respiratory management in preterm infants
Sanz E et al.
827